Navigation Links
Cellectis Publishes 2010 Financial Results
Date:3/31/2011

PARIS, March 31, 2011 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the genome engineering specialist, has announced its consolidated financial results for the financial year ended December 31, 2010.

Main financial items:

  • Total operating revenues increased by 55% between 2009 and 2010, from EUR 10.1M to EUR 15.8M. Growth was mainly driven by the increase in the Credit d'Impot Recherche, as a result of several major contracts (Boehringer Ingelheim, Bayer Healthcare and BASF Plant Science) and also by the consolidation of existing partnerships.

  • The development of subsidiaries and acquisition of complementary technologies led to an increase in operating expenses, totaling EUR 27.2M, up 37% from 2009.  

  • The net loss reached EUR 8M, slightly lower than the loss published for 2009, on a comparable basis.

  • The cash position came to EUR 24M at the end of 2010. Its evolution vs. 2009 was, for a third, due to temporary or non-recurring reasons: i/ the temporary augmentation of working capital requirement (Credit d'Impot Recherche increased by EUR 5M), and ii/ the acquisition of CytoPulse Inc.'s patents for EUR 1.5M.

  • Commenting on these results, Marc Le Bozec, Cellectis Chief Financial Officer, explained that "2010 was a year marked by the expansion of our technology and the development of our organization to support our research and marketing efforts. We significantly increased the sales effort of Cellectis bioresearch, formally structured our activities in the area of agrobiotechnology, and secured access to technologies that will help us to shorten the timeframe for bringing products into the market in the coming months."

    Key figures(based on IFRS -- International Financial Reporting Standards):

  • The company has decided to present, from now on, complete consolidated results according to IFRS, with more detail than the non-audited cons
    '/>"/>

  • SOURCE Cellectis
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
    2. Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting
    3. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
    4. Cellectis bioresearch Establishes The Genome Customization Award (TGCA)
    5. Taconics Litigation Contesting License Termination By Cellectis Is Dismissed
    6. Cellectis Unveils Its New Corporate Website
    7. Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store
    8. Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds
    9. Cellectis and the Center for iPS Cells Research and Application Enter Collaboration
    10. Cellectis Plant Sciences Licenses Plant Transformation Technology for Corn and Rice
    11. Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... Milpitas, Calif. (PRWEB) March 03, 2015 ... risk management excellence were honored by the Global ... annual event which took place on Wednesday, February 25th, ... , The GSCRC was formed to bring together supply ... thought leaders to advance the professional discipline through opportunities ...
    (Date:3/3/2015)... March 3, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... scientific journal, Expert Opinion on Biological Therapy , ... Zhenggang Zhang , at the Henry Ford Hospital ... Thymosin beta 4 (TB4) has the capacity to promote ... or more post-injury, leading to neurological recovery in each ...
    (Date:3/3/2015)... , March 3, 2015  Rosa & Co. ... drug-disease modeling and simulation research, today announced it has ... American Society for Clinical Pharmacology and Therapeutics meeting in ... 2015.   Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   ... will present a poster describing a quantitative systems pharmacology ...
    (Date:3/3/2015)... , March 3, 2015 Kindred Biosciences, Inc. (NASDAQ: ... and improving the lives of pets, announced today that it ... on March 12, 2015 after the market close. The Company ... that day. Interested parties may access the ... (484) 756-4262 internationally, and using conference ID 98449349.  ...
    Breaking Biology Technology:Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3
    ... HUBBARD, Ohio, Jan. 10, 2012   NanoLogix Inc. (PINK ... antibiotic sensitivity determination of live bacteria announces that has instructed ... submittal to the US FDA . The applications are ... for approval for use as a BSL-3 test process for ...
    ... and BEIJING, Jan. 10, 2012 The global fight ... Aeras and the China National Biotec Group (CNBG) announce ... new tuberculosis (TB) vaccines. The agreement between the leading ... biotechnology corporation in China signals a commitment by both ...
    ... in Spanish . Miguel A. Cazalilla, ... the Donostia International Physics Center (DIPC), together with other four ... was recently invited to write a review article that has ... Modern Physics of the American Physical Society, where only ...
    Cached Biology Technology:NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents 2NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents 3NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents 4Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D 2Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D 3Smaller and more powerful electronics requires the understanding of 'quantum jamming' physics 2
    (Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
    (Date:2/5/2015)... SAN FRANCISCO , January 28, 2015 ... Camera Market Analysis, Size And Segment Forecasts To 2020 ... The global IR camera market is expected to reach ... study by Grand View Research, Inc. IR cameras help ... injuries, and are expected to witness surging demand in ...
    (Date:2/5/2015)... , Feb. 3, 2015 Despite ... demand from industries such as consumer electronics, automotive, ... for surface mount technology (SMT) screen printers. Innovations ... automatic control will push the adoption curve up. ... remain steady as glue dispensers are indispensable in ...
    Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3
    ... responsible for the plague and some forms of food poisoning ... way, according to a new study in the September 8, ... , The researchers found that these bacteria, which belong to ... unrelated mammalian enzyme. That copycat protein blocks host cells' capacity ...
    ... yeast, University of Wisconsin-Madison researchers have uncovered novel functions of ... master regulatory switch -- a control that determines gene activity ... neurological disorders. , The work, published in the Dec. 8 ... in a single gene can have widespread effects on regulation ...
    ... Proteins called H2AX act as "first aid" to DNA, among ... world's most powerful light microscope (the only one of ... is distributed in the cell nucleus: in clusters, directing the ... it is really needed. , Many biological processes lie ...
    Cached Biology News:Study illuminates how the plague bacteria causes disease 2Study illuminates how the plague bacteria causes disease 3From a lowly yeast, researchers divine a clue to human disease 2Nanoscale microscope sheds first light on gene repair 2
    Request Info...
    Request Info...
    Loading Buffer...
    Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
    Biology Products: